CSIMarket


Zymeworks Inc   (ZYME)
Other Ticker:  
 
   Industry ../Industry/industry_valuation_ttm.php?pb&ind=803"> Major Pharmaceutical Preparations
   Sector  Healthcare

Zymeworks Inc

ZYME's Fundamental analysis








Looking into Zymeworks Inc growth rates, revenue grew by 1761.5 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 126

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -3.82 %

Zymeworks Inc realized net income compared to net loss a year ago in IV. Quarter 2022

More on ZYME's Growth


Zymeworks Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Zymeworks Inc PEG ratio is at -0.07 Company is currently trading with Price to Cash flow multiple of 2.8 in trailing twelve-month period.
Company
9.46
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 1.35.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.46.


More on ZYME's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 33.98
 Tangible Book Value (Per Share $) 6.95

Zymeworks Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Zymeworks Inc PEG ratio is at -0.07 Company is currently trading with Price to Cash flow multiple of 2.8 in trailing twelve-month period.
Company
9.46
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 1.35.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.46.

Zymeworks Inc Price to Book Ratio is at 1.13 higher than Indusry Avg. of 0.03, and higher than S&P 500 Avg. of -0.01

More on ZYME's Valuation

  Market Capitalization (Millions $) 558
  Shares Outstanding (Millions) 65
  Employees -
  Revenues (TTM) (Millions $) 412
  Net Income (TTM) (Millions $) 124
  Cash Flow (TTM) (Millions $) 199
  Capital Exp. (TTM) (Millions $) -13
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 33.98
  Tangible Book Value (Per Share $) 6.95

  Market Capitalization (Millions $) 558
  Shares Outstanding (Millions) 65
  Employees -
  Revenues (TTM) (Millions $) 412
  Net Income (TTM) (Millions $) 124
  Cash Flow (TTM) (Millions $) 199
  Capital Exp. (TTM) (Millions $) -13


    ZYME's Profitability Comparisons
Zymeworks Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 79.35 %.

Zymeworks Inc net profit margin of 76.88 % is currently ranking no. 9 in Major Pharmaceutical Preparations industry, ranking no. 20 in Healthcare sector and number 92 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 5.7
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.34
  Asset Turnover Ratio (TTM) 0.94
  Inventory Turnover Ratio (TTM) -



Zymeworks Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 79.35 %.

Zymeworks Inc net profit margin of 76.88 % is currently ranking no. 9 in Major Pharmaceutical Preparations industry, ranking no. 20 in Healthcare sector and number 92 in S&P 500.

More on ZYME's Key Ratios



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FGH's Profile

Stock Price

FGH's Financials

Business Description

Fundamentals

Charts & Quotes

FGH's News

Suppliers

FGH's Competitors

Customers & Markets

Economic Indicators

FGH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071